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Abstract
Objective. Healthcare-associated infection (HAI) surveillance programs are critical for infection prevention. Australia
does not have a comprehensive national HAI surveillance program. The purpose of this paper is to provide an overview of
established international and Australian statewide HAI surveillance programs and recommend a pathway for the devel-
opment of a national HAI surveillance program in Australia.
Methods. This study examined existing HAI surveillance programs through a literature review, a review of HAI
surveillanceprogramdocumentation, suchaswebsites, surveillancemanuals anddata reports anddirect contactwithprogram
representatives.
Results. Evidence from international programs demonstrates national HAI surveillance reduces the incidence ofHAIs.
However, the current status of HAI surveillance activity in Australian states is disparate, variation between programs is not
well understood, and the quality of data currently used to compose national HAI rates is uncertain.
Conclusions. There is a need to develop a well-structured, evidence-based national HAI program in Australia to meet
the increasing demand for validated reliable national HAI data. Such a program could be leveraged off the work of existing
Australian and international programs.
What is known about the topic? There is a large volume of literature demonstrating the effectiveness of national HAI
surveillance programs in reducing the incidence of HAIs. Although some of the larger states of Australia have individual
programs, a formalised national program does not exist. Awell structured national HAI program inAustralia would improve
the understanding of the epidemiology of HAIs in Australia and provide high quality data for performance monitoring and
ensuring that HAI prevention interventions are targeted appropriately.
What does this paper add? This paper reviews well established international HAI surveillance programs and highlights
the beneﬁts and limitations of these programs, and identiﬁes the gaps that currently exist inAustralia. Thepaper thenmapsout
a pathway towards the development of a national program.
What are the implications for practitioners? This paper will act as a guide for future research and policy activities
required for the establishment of a national HAI surveillance program in Australia.
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A healthcare-associated infection (HAI) is an infection that
occurs as a result of a health care intervention.1 Historically
called a ‘nosocomial’ infection, meaning ‘hospital acquired’, the
term ‘healthcare’ is now used in recognition that today much
health care occurs outside a hospital. Examples of HAIs are
bloodstream infections commonly caused by the presence of an
intravenous device, or an infected surgical wound following a
surgical procedure. Many HAIs result in signiﬁcant morbidity
and mortality.2 It is estimated that in Europe and North America,
12–32% of HAI bloodstream infections result in death.3 In
Australia, it has been suggested that 175 000 HAIs occur annu-
ally,4 but the exact ﬁgure is unknown.
Surveillance is deﬁned as ‘the ongoing, systematic collection,
analysis and interpretation of health data essential to the planning,
implementation, and evaluation of public health practice, closely
integrated with the timely dissemination of these data to those
who need to know’.5 It is a fundamental component of modern
health care, demonstrated by the recently released national safety
and quality health service standards for Australian hospitals that
include 19 criteria on the prevention and control of HAIs, and
speciﬁcally mandate HAI surveillance.6
By its very existence, infection prevention implies that HAIs
are preventable. Although it is challenging to quantify the pre-
ventable proportion of HAIs, there is agreement that a signiﬁcant
proportion and probably the majority of HAIs are preventable.7,8
The purpose ofHAI surveillance is to provide quality data that
can act as an effective monitoring and alert system.9 The aim is
to reduce the incidence of preventable HAIs. A successful HAI
surveillance program must be epidemiologically robust, valid,
accurate, timely, useful, consistent and practical.5
Effective surveillance will deliver information to key stake-
holders at all levels to inform decisions. The simple act of
collecting HAI data will not reduce HAI;10 rather, data must
stimulate action and drive improvement. HAI surveillance sys-
tems establish a baseline rate of infection which can then be used
to detect clusters or outbreaks, identify problems, evaluate pre-
vention and control measures, generate hypotheses concerning
risk factors, guide treatment and prevention strategies, make
comparisons with other facilities, inform planning and ultimately
reduce the incidence of HAIs.11–14
Australia is one of the few developed countries without a
national HAI surveillance program.Unlike theUS,UKandmany
European countries,who have supported andmaintained national
HAI surveillance programs for decades, Australia lacks well
structured processes to produce high quality national HAI data.
In the UK and some states in the US, reporting of some HAIs has
been mandated by law.15,16 Such international programs enable
research on the epidemiology of HAIs, which also leads to
enhanced and reﬁned surveillance processes improving the qual-
ity of the HAI data now commonly reported in the public
domain.17,18 In the US, hospitals are ﬁnancially penalised on
the occurrence of events, many of them HAIs, which are deemed
preventable.19
Recent activity in Australia to develop national guides for the
implementation of surveillance on Staphylococcus aureus
bloodstream (SAB) infection, Clostridium difﬁcile infection
(CDI) and central line-associated bloodstream infection20 is
positive but there is still much work to be done to improve our
knowledge on the epidemiology of HAIs across Australia.
The purpose of this paper is to review well established
international HAI surveillance programs and their impact onHAI
rates, provide an overviewof currentAustralianHAI surveillance
programs and recommend a way forward to develop a national
HAI surveillance program. This review focuses on the surveil-
lance of infections in large acute public healthcare facilities,
where the risk and consequences of infection are higher due to
the nature of the care that takes place.
Methods
A review of current literature on national HAI surveillance
programs was undertaken to identify existing national programs.
The MEDLINE database from 1966 to 2013 was used by
searching these key terms: cross-infection, nosocomial infection,
nosocomial infection rates, healthcare-associated infection,
healthcare-associated infection rates, surveillance, infection pre-
vention and infection control. Australian jurisdictional programs
and national programs from overseas that were the best described
in the literature were then selected for review. To gain further
information on international programs, a review of program
websites, surveillance manuals, annual reports and data reports
(where available) was performed, and program representatives
from Germany, UK, Spain, Scotland and the Netherlands were
contacted directly for clariﬁcation. For Australian surveillance
activities, information was sourced from program websites and
manuals, and representatives from each program were contacted
for conﬁrmation and clariﬁcation.
Results
International HAI surveillance programs and impact
The longest running national HAI surveillance program is the
Centers for Disease Control’s National Healthcare Safety Net-
work in the US.21 Originally called the National Nosocomial
Infection Surveillance (NNIS) system, it commenced in 1970
with 62 hospitals voluntarily participating.21 In 2005, the pro-
gram expanded to include coexisting healthcare worker exposure
and renal dialysis surveillance programs to create the National
Healthcare Safety Network.22 The deﬁnitions and methodology
developed by the initial NNIS programhave been largely adopted
by many programs internationally.18
In the US, a review of HAI rates in hospitals participating in
NNIS between 1990 and 1999 demonstrated decreases in urinary
tract, respiratory tract and bloodstream infections monitored in
intensive care units.23 Reductions in bloodstream infection rates
varied from 31% to 44%. The authors acknowledge that other
explanations, such as a national effort to reduce HAIs, may have
also inﬂuenced these results.24
Other well described national HAI surveillance programs
include the Krankenhaus Infektions Surveillance System (KISS)
inGermany,25 theUK,26 Spain,27,28 France,29 Scotland,30 and the
Netherlands.31
InGermany,Gastmeier demonstrated signiﬁcant reductions in
HAI of 20–30% over a 3-year period in hospitals participating in
the Krankenhaus Infektions Surveillance System program. Sig-
niﬁcant reductions of 24–57% in surgical site infections (SSI)
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have been demonstrated in the Netherlands and Denmark fol-
lowing the introduction of national surveillance.32 A review of
SSI in France over 6 years following the introduction of surveil-
lance demonstrated a 30% reduction in the ﬁrst 3 years, with an
ongoing decrease in infection rates over the next 3 years.29 In the
Netherlands, SSI surveillance commenced in 1996 as a compo-
nent of the new national HAI surveillance program ‘PREZIES’.
Geubbels et al. claim that surveillance led to a decrease in the risk
of SSI of 31% when measured 4 years from the introduction of
the program and a decrease of 57% in its ﬁfth year.33
Current issues with international programs
A recent review of international surveillance programs noted that
despite being similarly structured and following international
recommendations and standardised deﬁnitions, widespread var-
iation existed between programs.34 Grammatico-Guillon et al.
identiﬁed variation in data collection methods and quality due to
differences in the category of staff performing surveillance,
variable data sources, prospective and retrospective data collec-
tion, and the presence of routine post-discharge surveillance.34 It
was also noted that validation of data did not occur on a regular
basis.34
Traditional surveillance methods are time-consuming, appli-
cation of deﬁnitions is subject to interpretation and identiﬁcation
of cases is dependent on effort.35 Infection prevention staff spend
up to 45% of their time undertaking surveillance.36 As Perl and
Chaiwarth note, the integration of rapidly developing surveil-
lance technologies is essential to the future of HAI surveillance.
Electronic HAI surveillance systems can reduce the time spent by
up to 65% compared with traditional surveillance methods, and
improved sensitivity or speciﬁcity can be demonstrated.13 Recent
studies have highlighted the advantages of using modern tech-
nology, such as the increased accuracy of hospital rankings when
computer algorithms are used.37,38
Attempts have been made to use administrative code data to
identify HAIs, but a recent systematic review found the use of
administrative code data continues to demonstrate only moderate
sensitivity.3 Goto et al. recommend that administrative code data
may be useful as a factor within an algorithm but should not be
used as the primary case-ﬁnding method.3
The use of automated technology and electronic data as an
aid to traditional HAI surveillance methods has been well de-
scribed.39 Automated systems ensure consistent application of
surveillance deﬁnitions, signiﬁcantly reduce the burden of data
management, and provide improved sensitivity and speciﬁcity.39
Current situation in Australia
Of Australia’s eight states and territories, several States imple-
mented HAI surveillance programs during the 1990s and
2000s, using infection deﬁnitions based on those developed by
NNIS.40–43
In December 2008, the Australian Health Ministers’ Confer-
ence endorsed jurisdictional level surveillance of SAB and
CDI. This was followed in 2009 by further endorsement of the
Australian Commission on Safety and Quality in Health Care
(ASQHC) recommendation that hospitals routinely monitor
SAB and CDI.
A comparison of surveillance components considered man-
datory in existing statewide programs is demonstrated in Table 1.
There is consistency in intensive care unit central line-associated
Table 1. Comparison of mandatory healthcare associated infection surveillance components in acute care public facilities by state
All states and territories in Australia undertake surveillance for Staphylococcus aureus bloodstream (SAB) infection and Clostridium difﬁcile infection (CDI).
, surveillance performed; ß, surveillance not performed; 1, with modiﬁcations; 2, including neonatal intensive care unit (NICU); 3, NICU only; 4, if >50
procedures per year; 5, Royal Women’s hospitals and Women’s Mercy Hospital only; 6, infections only; BSI, bloodstream infection; CABG, coronary artery
bypass graft; CHRISP, Centre for Health Related Infection Surveillance and Prevention; HAI, healthcare-associated infection; HISWA, Healthcare Infection
Surveillance Western Australia; ICU, intensive care unit; MRSA, methicillin-resistant Staphylococcus aureus; MRAB, multi-resistant Acinetobacter;
NHSN, National Health and Safety Network; NA, not applicable; SSI, surgical site infection; TIPCU, Tasmanian Infection Prevention and Control Unit;
VICNESS, Victorian Healthcare Associated Infection Surveillance System


















Central line-associated BSI in ICU (includes peripherally inserted)    ß 2 
Acquisition of MRSA in ICUB    ß ß 6
Acquisition of MRAB in ICUB    ß ß 6
CABG   ß ß  ß
Hip prosthesis   ß ß 4 
Knee prosthesis   ß ß 4 
Lower Caesarean section ß ß ß ß 5 ß
SSI post-discharge surveillance included (except for readmissions) ß A ß ß A A
NHSN deﬁnitions 1 1  NA  1
All MRSA infections ß   ß ß 
Haemodialysis access-associated BSI ß  ß ß ß 
Hospital-wide BSI ß   ß ß ß
AOptional.
BIncludes colonisation and infection.
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bloodstream infection and SSI surveillance of knee and hip
replacement surgery across the larger states. However, there is
inconsistency in mandatory surveillance components, deﬁni-
tions, and post-discharge surveillance. Not included in the table
due to the large degree of variation is inconsistency identiﬁed
with regards to multiresistant or signiﬁcant organism surveil-
lance. Although some states report multiresistant or signiﬁcant
organism surveillance programs, others do not. The intensity of
surveillance undertaken is peculiar to each jurisdiction with
respect to the type of organism, infection versus colonisation,
site, healthcare-associated versus hospital-onset infection,
and requirements for the data to be notiﬁed at a state level.
In Tasmania and Western Australia, notiﬁcation of SAB is
mandated.
Anecdotally, it is reported that many hospitals, networks
and regions undertake HAI surveillance above and beyond the
mandatory requirements of their jurisdiction. Examples
include individual hospitals performing targeted surveillance in
unique high-risk populations or in response to perceived pro-
blems. The extent of this activity and the quality of the data is
unknown.
Discussion
This review has identiﬁed well established international HAI
surveillance programs with evidence of a reduction of HAI rates,
whilst highlighting some of the major gaps in HAI surveillance
activities undertaken across Australia.
The evolution of HAI surveillance programs in Australia has
been fragmented. Although some of the jurisdictional programs
are now well established and embedded into routine health care
safety and quality processes, it could be argued that without clear
national direction, the programs have evolved in a competitive
environment. This has resulted in variation among methods,44
duplication of effort and a limited ability to collate and analyse
data at a national level. Potential differences between programs
deserving of further research include the level of training of those
involved in HAI surveillance, data analysis and reporting.
Unlike international programs, there is a lack of evidence
demonstrating the effect of these statewideprogramsonHAI rates
over time, although two of these programs have published
validation studies.43,45–47
Current ASQHC strategies such as the National Surveillance
Initiative20 have promoted and supported increased jurisdictional
collaboration. The development of national deﬁnitions for SAB
and CDI have been followed by identiﬁable hospital SAB data
regularly published on the MyHospitals website.48 Although
concerns regarding the validity and lack of risk adjustment49–51
need to be addressed, the work of the ACSQHC HAI program
continues to provide direction for further national HAI surveil-
lance activity. The recently completed ACSQHC report on
antimicrobial resistance and antibiotic usage adds to the drive
for better national HAI surveillance processes.52
Beneﬁts of an Australian HAI surveillance program
As key stakeholders, consumers, healthcare workers and policy
makers will all beneﬁt from a well constructed national HAI
surveillance program. Consumers clearly stand to gain from
improved quality of care, resulting in reduced risk of acquiring
a HAI. Healthcare workers will beneﬁt from improved efﬁciency
in surveillance processes that could relieve the current burden of
data collection. The development of national education programs
for those undertaking HAI surveillance will be uniformly acces-
sible across Australia. The ready availability of benchmarking
data will assist hospitals to allocate resources for infection
prevention activities appropriately.Meaningful national compar-
isons of HAI rates by hospital size, type, speciality and, poten-
tially, by speciﬁc patient risk factors will provide important
contextual data across Australia. A comprehensive HAI surveil-
lanceprogramwill provide analysis and interpretationofdata, and
drive investigation into unusual ﬁndings. This will lead to a
sharing of information and, through informed policy making,
will ultimately beneﬁt patient care.
The ability to describe the epidemiology ofHAIswill improve
our understanding of the difference between populations. De-
tailed datawill enable the identiﬁcation of problem areas thatmay
require more infection prevention resources and similarly high-
light successful interventions that could act as role models and
inform policy on state and national infection prevention initia-
tives. Itwill provide the foundation for local research initiatives to
improve the safety and quality of health care to patients.
Where to from here?
In 2010, major infection prevention bodies including the Asso-
ciation for Professionals in Infection Control and Epidemiology,
the Society for Healthcare Epidemiology of America, the Infec-
tious Diseases Society of America, and the Centers for Disease
Control and Prevention proposed four pillars for the elimination
ofHAIs, the fourth of whichwas ‘data to target prevention efforts
andmeasureprogress’.53Todeliver timelyhigh-qualitydata, they
recommended’1 reshaping standard deﬁnitions and surveillance
methods to ﬁt the new, emerging information system paradigms
(e.g. electronic health information records and data mining);2
creating national and global data standards for key HAI preven-
tion metrics; and3 creating or reﬁning the data analysis and
presentation tools available to prevention experts, clinicians
and policy makers at the local, state, national and international
levels.’53 Thesewill provide valuable direction for a nationalHAI
program in Australia.
There is much to be done in identifying a framework for a
national surveillance program and the potential is exciting. First,
we must take stock of the current situation in Australia to
understand precisely the what, how and why of HAI surveillance
currently being undertaken. To clearly identify, measure and
describe exactly how much variation exists between hospitals
and states, and how this inﬂuences outcomes is necessary to
inform future endeavours. Information requirements need to be
balanced against available resources and it is possible that current
processes already exist that may be suitable to be extended into
the national arena, and that better use of current data may be
achievable. Although SAB data are currently being reported
publicly, it is important that the data are validated and appropri-
ately risk adjusted for meaningful comparisons to be made.
Further, a meaningful way to report national CDI data that is
currently collected needs to be identiﬁed.
Second, the resources, skill level and experience of those
involved in current HAI surveillance will inﬂuence the quality of
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the program. An understanding of the ideal mix of these char-
acteristics is essential.
Third, we must explore the use of technology as an aid to
efﬁcient HAI surveillance processes. Efﬁcient data collection
processes remain elusive. Current manual data collection meth-
ods are unsustainable and impedewider surveillance activity, so it
is essential that the inclusion of automated electronic surveillance
systems is considered. Existing data that are readily accessible
may inform efforts to identify an agreed minimum level dataset
for some HAIs.
Fourth, we must identify the key components of successful
programs. No program will be perfect, but there are decades of
lessons to be learnt from our colleagues across the world.
Similarly, we must also draw upon the experience of our local
experts andengageall key stakeholders to identify thebarriers and
enablers for national HAI surveillance. For example, a model
mapping out the inﬂuences on reliable and valid HAI data has
recently been developed by Australian researchers.54
Conclusion
Evidence clearly demonstrates that national HAI surveillance
programs provide meaningful, reliable and valid data that ulti-
mately reduce the incidence of HAIs. Although Australian jur-
isdictions continue to conduct disparate HAI surveillance
programs, the utility of data at a national level remains limited.
Centrally coordinated international HAI surveillance programs
may act as a model for an Australian system, which could be
further enhanced through the use of technology. The lack of a
national program in Australia presents a unique opportunity to
construct a HAI surveillance program based on the best available
evidence.
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